HIGH LINE BIO Trademark

Trademark Overview

On Thursday, December 16, 2021, a trademark application was filed for HIGH LINE BIO with the United States Patent and Trademark Office. The USPTO has given the HIGH LINE BIO trademark a serial number of 97174951. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 6, 2024. This trademark is owned by High Line Bio, Inc.. The HIGH LINE BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
high line bio

General Information

Serial Number97174951
Word MarkHIGH LINE BIO
Filing DateThursday, December 16, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

NOT AVAILABLE"BIO"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHigh Line Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameHigh Line Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, December 20, 2021NEW APPLICATION ENTERED
Monday, December 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 6, 2024SOU EXTENSION 2 GRANTED
Thursday, June 6, 2024SOU EXTENSION 2 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 5, 2023SOU EXTENSION 1 FILED

Related Keywords

line high development research pharmaceutical